Connexion
Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value
21 novembre 2025 à 22:25
The 150-year-old drugmaker is the first company in health care to hit the milestone.
Eli Lilly, based in Indianapolis, has surged in large part because of the company’s success in commanding the GLP-1 weight loss drug market.
© Scott Olson/Getty Images
